Literature DB >> 34034966

Papillary renal cell carcinoma: Review.

Neil Mendhiratta1, Peter Muraki1, Anthony E Sisk2, Brian Shuch3.   

Abstract

Kidney cancer is the 13th most common malignancy globally, and the incidence is rising. Papillary renal cell carcinoma is the second most common subtype, comprising 10-15% of renal cell carcinomas. Though the histologic features of this subtype were initially described in the 1990's, our understanding of the genetic and molecular characteristics of this disease have rapidly evolved over the past decade. In this review, we summarize the contemporary understanding of the clinical, morphologic, radiographic, and genetic characteristics of papillary renal cell carcinoma, as well as clinical considerations, current options for management, and prognosis.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34034966     DOI: 10.1016/j.urolonc.2021.04.013

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  4 in total

1.  Giant Polycystic Papillary Renal Cell Carcinoma: A Case Report and Literature Review.

Authors:  Zhongming Huang; Hai Wang; Zhigang Ji
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

2.  Comprehensive Analysis of Pyroptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Papillary Renal Cell Carcinoma.

Authors:  Chiyu Zhang; Ruizhen Huang; Xiaoqing Xi
Journal:  Front Mol Biosci       Date:  2022-03-23

3.  Unique Growth Pattern Presentation of a Papillary Renal Cell Carcinoma.

Authors:  Octavia Oana Harich; Gheorghe-Emilian Olteanu; Ioana Maria Mihai; Marius Benta; Gavriliuc Oana Isabella; Paunescu Virgil; Florina Maria Bojin
Journal:  Diagnostics (Basel)       Date:  2022-08-06

4.  Identification of potential biomarkers associated with immune infiltration in papillary renal cell carcinoma.

Authors:  Ran Deng; Jianpeng Li; Hong Zhao; Zhirui Zou; Jiangwei Man; Jinlong Cao; Li Yang
Journal:  J Clin Lab Anal       Date:  2021-10-04       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.